Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
RVLPQ Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: August 28, 2023
Report Source: 2023 2nd Quarter Report
RVL Pharmaceuticals PLC. Stock Analysis RVLPQ
United States Health Care Nano Cap Report: RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The firm is focused on developing and commercializing products for an underserved patient population in ocular medicine and medical aesthetics. The company operates in one business segment which focuses on developing and commercializing pharmaceutical products. The firm is commercializing Upneeq for treating acquired blepharoptosis (low-lying eyelids) in adults and is developing Arbaclofen ER tablets for alleviating spasticity in multiple sclerosis patients. Their healthcare provider customers include optometrists, ophthalmologists, oculoplastic surgeons, facial plastic surgeons, dermatologists, and other qualified practitioners. The target patient population comprises adults with droopy or low-lying eyelids, primarily females. Its commercial operations are managed by wholly owned subsidiaries, RVL Pharmaceuticals, Inc., and RVL Pharmacy, LLC.
Read More RVL Pharmaceuticals PLC (RVLPQ) Chart
Financial Metrics & Statements of RVL Pharmaceuticals PLC (RVLPQ)
FAQ's for RVL Pharmaceuticals PLC (RVLPQ)
- According to Musaffa’s Shariah screening methodology, RVL Pharmaceuticals PLC (RVLPQ) is currently classified as NOT HALAL as of August 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes RVL Pharmaceuticals PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in RVL Pharmaceuticals PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of RVL Pharmaceuticals PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of RVL Pharmaceuticals PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of RVL Pharmaceuticals PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.